PATENT CLAIM ANALYSIS

Application Number: 15892140
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "001100"]

Abstract:
Provided herein are peptides comprising an amino acid sequence having at least about 85% sequence identity to RYRPRAPIIAVT (SEQ ID NO: 1). These cationic peptides inhibit PKM2 methylation and may be used in the treatment of breast cancer and other diseases or conditions in which PKM2 is overexpressed. Such PKM2 peptides may be delivered to cancer cells using pH sensitive unimolecular nanoparticles comprising anionic polymers.

Claim (Index 20):
A kit comprising a package containing unimolecular nanoparticle of  claim 10  and a package containing an effective amount of therapeutic cationic peptide and directions for use of the kit.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 88.0
- Lexical Diversity: 1.24138
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15555482', '15551995', '13516511', '15563533', '15383454']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7158625855753964
- 35 USC 102 Novelty (BERT): 0.5044185590568278
- Combined Prediction Score: 0.6947181829235395
- Mean Citation Score: 200.830826
- Max Citation Score: 225.31363
- Similarity Product: 142.07729024371622

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test